FDA Adverse Event Malfunction Summary report: N

COAGUCHEK ® XS SYSTEM

MDR report key: 17385853 · Received July 24, 2023

Report

Report Number
1823260-2023-02458
Event Type
Malfunction
Date Received
July 24, 2023
Date of Event
July 5, 2023
Report Date
July 24, 2023
Manufacturer
ROCHE DIAGNOSTICS
Product Code
GJS
UDI-DI
00365702127104
PMA / PMN Number
K062925
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

E3-OCCUPATION IS PATIENT/CONSUMER ON A REGULAR BASIS, COAGUCHEK STRIPS OF LOTS CURRENTLY VALID IN THE MARKET ARE TESTED AS PART OF ROUTINE RETENTION TESTING AND RESULTS HAVE PASSED THE INTERNAL INSPECTION. PRODUCT LABELING STATES: "THE COAGUCHEK SYSTEM USES HUMAN RECOMBINANT THROMBOPLASTIN. THEREFORE, THE COMPARABILITY TO OTHER HUMAN RECOMBINANT THROMBOPLASTINS IS BEST, WHEREAS DEVIATIONS CAN OCCUR WHEN COMPARED TO METHODS USING OTHER THROMBOPLASTINS. HOWEVER, THOSE DEVIATIONS BETWEEN THROMBOPLASTINS OF DIFFERENT ORIGIN (E.G., RABBIT BASED) ARE NOT SPECIFIC TO COAGUCHEK PRODUCTS. SIMILAR DIFFERENCES CAN BE OBSERVED WHEN A HUMAN RECOMBINANT THROMBOPLASTIN BASED LABORATORY METHOD IS COMPARED TO OTHER LABORATORY METHODS." THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE CAUSE OF THE EVENT COULD NOT BE DETERMINED. N.

Description of Event or Problem · 0

WE RECEIVED AN ALLEGATION OF DISCREPANT INR RESULTS WITH COAGUCHEK XS METER SERIAL NUMBER (B)(6) COMPARED TO A LABORATORY USING AN UNKNOWN REAGENT. AT 5:15 PM, THE METER RESULT WAS 4.4 INR. THE PATIENT WAS NOT FEELING WELL SO THEY WENT TO THE ER FOR A LAB TEST. AT 6:45 PM TO 7:00 PM, THE RESULT FROM THE LABORATORY WAS 2.65 INR. THE PATIENT'S THERAPEUTIC RANGE IS 2.0-3.0 INR. THE PATIENT'S TESTING FREQUENCY VARIES BETWEEN WEEKLY TO MONTHLY BASED ON IF THEY ARE IN THEIR NORMAL RANGE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
632424 COAGUCHEK ® XS SYSTEM PROTHROMBIN TIME TEST STRIPS GJS ROCHE DIAGNOSTICS NA 65031621 00365702127104

Patients

Seq Age Sex Outcome Treatment
1 57 YR Male AMOXICILLIN| ATORVASTATIN| BIKTARVY| CARVEDILOL| DOXYCYCLINE| DULOXETINE| OTEZLA| PANTOPRAZOLE| TYLENOL 3| WARFARIN